The Patent Finder

United Biomedical, Inc.

Also on record
Records under this name other than the patents United Biomedical, Inc. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 4 patents it holds.

Back to United Biomedical, Inc.

PatentTitleStatus Expires Confidence
US 9,102,752Peptide vaccine for prevention and immunotherapy of dementia of the Alzheimer's type
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 11,180,555Antibodies directed against CD4 for the treatment and functional cure of HIV
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 8,084,015Stabilized synthetic immunogen delivery system
Term ended
Term ended Apr 14, 2026 · From the USPTO record
Term endedTerm ended Apr 14, 2026From the USPTO record
US 9,932,372Designer peptide-based PCV2 vaccine
Lapsed on the fee record
Ended Apr 3, 2026 · From the USPTO record
Lapsed on the fee recordEnded Apr 3, 2026From the USPTO record
US 8,088,388Stabilized synthetic immunogen delivery system
Term ended
Term ended Jul 26, 2025 · From the USPTO record
Term endedTerm ended Jul 26, 2025From the USPTO record
US 7,501,494Designed deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection
Formerly held
Term ended
Term ended Sep 20, 2024 · From the USPTO record
Term endedTerm ended Sep 20, 2024From the USPTO record
US 7,872,110Deimmunized monoclonal antibodies for protection against HIV exposure and treatment of HIV infection
Formerly held
Term ended
Term ended Jan 15, 2023 · From the USPTO record
Term endedTerm ended Jan 15, 2023From the USPTO record
US 7,951,909Immunogenic peptide composition comprising a promiscuous helper T cell epitope and an N-terminal fragment of Aβ1-42 peptide
Formerly held
Term ended
Term ended Jun 24, 2022 · From the USPTO record
Term endedTerm ended Jun 24, 2022From the USPTO record
US 6,906,169Immunogenic peptide composition comprising measles virus Fprotein Thelper cell epitope (MUFThl-16) and N-terminus of β-amyloid peptide
Formerly held
Term ended
Term ended Jun 14, 2022 · From the USPTO record
Term endedTerm ended Jun 14, 2022From the USPTO record
US 8,232,373Immunogenic peptide composition for the prevention and treatment of alzheimer's disease
Formerly held
Term ended
Term ended May 25, 2021 · From the USPTO record
Term endedTerm ended May 25, 2021From the USPTO record
10 of 46 patents shown.
Pro members see all 46.
Pro members: see all 46 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited